Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Neoadjuvant Therapy × 30 days × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Nivolumab 19 cabozantinib 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Specimen Handling 12 Ipilimumab 12 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 avelumab 2 aldesleukin 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡